Project Details
Description
An observational retrospective cohort study of systemic therapies for relapsed or refractory diffuse large B cell lymphoma (R/R DLBCL), to compare outcomes to those from Tafasitamab + Lenalidomide in the L-MIND study
| Status | Finished |
|---|---|
| Effective start/end date | 6/30/20 → 4/28/21 |
Funding
- MorphoSys AG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.